European Archives - Page 547 of 1196 - European Medical Journal

Sanofi lights ‘Beacon of Hope’ in race for greater diversity

Sanofi has joined the ‘Beacon of Hope’ programme – a Novartis initiative seeking to address racial inequality in clinical trials, health and education and to create greater diversity across R&D structures.

Next Step in Incretin-Based Therapy: From Single to Dual Agonism

The incretin effect, an augmented prandial insulin response, is mediated mostly by the hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), which are released from the intestines after meals.

Allergies, Anaphylaxis and Beyond: Insights from a Paediatric Allergist

This week, Adam Fox, Chair of the UK National Allergy Strategy Group joined Evgenia to talk all things allergy.

New Treatment Options in Paediatric Thalassemia

The third of our six-part series focuses on new treatment options in paediatric thalassemia with expert Dr Immacolata Tartaglione, paediatrician at University of Campania Luigi Vanvitelli in Napoli, Italy.

Feature Image Cardio Supp 3

EMJ Cardiology 10 [Supplement 3] 2022

This article summarises the groundbreaking research and personalised approach to atherosclerotic cardiovascular disease…

EMJ Hematology 10.1 2022 Feature Image

EHA 2022 Abstract Highlights

The following highlights focus on several insightful and innovative abstracts at the European Hematology Association (EHA) 2022 hybrid…

EMJ Hematology 10.1 2022 Feature Image

EMJ Hematology 10.1 2022

Welcome to our latest issue of EMJ Hematology, which brings you quality content on the latest developments in the field and a review of the European Hematology Association (EHA) 2022 Hybrid Congress, with key highlights from the event. Featured articles include a review of the social impact and quality of life for patients with β-thalassaemia, and an article on how helical tomotherapy may be used as a valid and effective treatment for compressive atelectasis due to extramedullary haematopoiesis.

EMJ Hematology 10.1 2022 Feature Image

Zamtocabtagene Autoleucel (MB-CART2019.1): An Investigational CAR-T Cell Product with Tandem Targeting of CD19 and CD20 as a Potential Treatment Option for Patients with Relapsed/ Refractory B Cell Non-Hodgkin Lymphoma

Presenting at the European Hematology Association (EHA) 2022 Congress, Peter Borchmann from the University of Cologne, Germany…

EMJ Hematology 10.1 2022 Feature Image

Exploring a Role for Mitapivat in Children with Pyruvate Kinase Deficiency

Three posters presented at the European Hematology Association (EHA) 2022 Hybrid Congress focused on the role of mitapivat in the…

EMJ Hematology 10.1 2022 Feature Image

Review of the European Hematology Association 2022 Hybrid Congress

THE EUROPEAN Hematology Association (EHA) successfully brought together clinicians and researchers from all over the world to share the latest advances in the field of haematology in its 27th Annual Congress, and its first ever hybrid congress.